Klotho Neurosciences (NASDAQ:KLTO) Shares Down 1.8% – Time to Sell?

Klotho Neurosciences, Inc. (NASDAQ:KLTO) shares traded down 1.8% on Thursday . The company traded as low as $0.27 and last traded at $0.28. 12,690 shares were traded during trading, a decline of 98% from the average session volume of 824,509 shares. The stock had previously closed at $0.28.

Klotho Neurosciences Stock Up 6.5 %

The company has a 50-day moving average price of $0.36.

Institutional Investors Weigh In On Klotho Neurosciences

A hedge fund recently raised its stake in Klotho Neurosciences stock. Geode Capital Management LLC boosted its stake in shares of Klotho Neurosciences, Inc. (NASDAQ:KLTO) by 122.4% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 140,606 shares of the company’s stock after acquiring an additional 77,372 shares during the period. Geode Capital Management LLC owned 0.52% of Klotho Neurosciences worth $68,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 20.07% of the company’s stock.

Klotho Neurosciences Company Profile

Klotho Neurosciences, Inc, a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors.